Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children of China: A single-center observational study

The treatment of severe chronic immune thrombocytopenia (SCITP) in pediatric patients is challenging. We evaluated the clinical efficacy and safety of eltrombopag in children with SCITP in China. This observational study was carried out at the Hematology Oncology Center, Beijing Children’s Hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xiaoling, Yan, Kuo, Ma, Jingyao, Chen, Zhenping, Zhao, Libo, Wang, Xiaoling, Wu, Runhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710667/
https://www.ncbi.nlm.nih.gov/pubmed/31438744
http://dx.doi.org/10.1177/2058738419872120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710667/
https://www.ncbi.nlm.nih.gov/pubmed/31438744
http://dx.doi.org/10.1177/2058738419872120

Ejemplares similares